FV 47 Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis. Issue 8 (August 2019) - Hauser, S.; Hartung, H.P.; Kappos, L.; Montalban, X.; Hughes, R.; Koendgen, H.; McNamara, J.; Pradhan, A.; Wormser, D.; Wolinsky, J.S.